Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-24-011223

Executive Vice President & CFO gave up 30,790 shares (to pay taxes)

  • Executive Vice President & CFO acquired 87,720 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Konidaris Tasos Executive Vice President & CFO 2024-03-12 Option exercise +87,720 558,106 D
Konidaris Tasos Executive Vice President & CFO 2024-03-12 Shares withheld for taxes −30,790 $5.31 $163,495 527,316 D
Derivatives
Konidaris Tasos Executive Vice President & CFO 2024-03-12 Option exercise · Restricted Stock Units −87,720 0 D
Loading xslF345X05/wk-form4_1710447463.xml…